iShares iBonds Dec 2025 Term USD Corp UCITS ETF AccumUSD
The iShares iBonds Dec 2025 Term USD Corp UCITS ETF AccumUSD (Ticker: GB:ID25) is a sophisticated financial instrument designed for investors seeking targeted exposure to the corporate bond market. This exchange-traded fund (ETF) is categorized under Corporate, focusing specifically on Broad Credit with a strategic emphasis on the short-term niche. This ETF offers a unique approach to fixed-income investing by providing a diversified portfolio of U.S. dollar-denominated corporate bonds that mature in December 2025.
A key feature of the iShares iBonds Dec 2025 ETF is its defined maturity date, which allows investors to manage their fixed-income exposure with precision, similar to individual bonds, but with the diversification benefits of an ETF. As it approaches its maturity date, the fund gradually shifts its composition to reduce interest rate risk, making it an attractive option for investors looking to manage their credit exposure while minimizing volatility.
This ETF is particularly suited for investors seeking to balance income generation with capital preservation within a short-term investment horizon. By focusing on broad credit, the fund captures opportunities across the corporate bond spectrum, providing a comprehensive exposure to high-quality credit instruments. The accumulation structure of the ETF means that income is reinvested, compounding potential returns within the fund, which is ideal for investors looking to enhance their portfolio's growth over a defined period.
The iShares iBonds Dec 2025 Term USD Corp UCITS ETF AccumUSD is a compelling option for astute investors who value the predictability of bond investing with the added benefits of ETF liquidity and diversification.
iShares iBonds Dec 2025 Term USD Corp UCITS ETF AccumUSD (ID25) Fund Flow Chart
iShares iBonds Dec 2025 Term USD Corp UCITS ETF AccumUSD (ID25) 1 year Net Flows: -$71M
ID25 ETF FAQ
What was GB:ID25’s price range in the past 12 months?
GB:ID25 lowest ETF price was $105.32 and its highest was $110.74 in the past 12 months.